Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-24-000277·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2024-11-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 12,104,911 · Class: 10.4%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 6,201,300 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000277
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Dec 06, 2024
- Reporting period
- Nov 29, 2024
- Description
- Schedule 13G beneficial ownership